Wolff Wiese Magana’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15K Hold
25
﹤0.01% 814
2026
Q1
$2.26K Hold
25
﹤0.01% 759
2025
Q4
$2.25K Hold
25
﹤0.01% 732
2025
Q3
$2.46K Hold
25
﹤0.01% 721
2025
Q2
$2.28K Hold
25
﹤0.01% 704
2025
Q1
$2.83K Sell
25
-5
-17% -$535 ﹤0.01% 673
2024
Q4
$3.17K Buy
30
+5
+20% +$536 ﹤0.01% 634
2024
Q3
$2.7K Hold
25
﹤0.01% 684
2024
Q2
$2.71K Hold
25
﹤0.01% 507
2024
Q1
$3.3K Hold
25
﹤0.01% 451
2023
Q4
$3.04K Sell
25
-6
-19% -$669 ﹤0.01% 438
2023
Q3
$3.48K Sell
31
-41
-57% -$5.21K ﹤0.01% 480
2023
Q2
$10.5K Hold
72
0.01% 342
2023
Q1
$9.3K Hold
72
0.01% 358
2022
Q4
$9.18K Hold
72
0.01% 338
2022
Q3
$8K Hold
72
0.01% 538
2022
Q2
$8K Hold
72
0.01% 573
2022
Q1
$9K Sell
72
-2
-3% -$241 0.01% 556
2021
Q4
$9K Sell
74
-47
-39% -$6.15K 0.01% 572
2021
Q3
$18K Sell
121
-3
-2% -$441 0.01% 437
2021
Q2
$20K Sell
124
-249
-67% -$40.3K 0.01% 399
2021
Q1
$58K Buy
373
+41
+12% +$6.35K 0.05% 254
2020
Q4
$50K Buy
+332
New +$46.9K 0.04% 267

Other funds holding ZBH

Wolff Wiese Magana's ZBH Position: Q2 2026 in Review

Wolff Wiese Magana held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 25 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #814.

Wolff Wiese Magana first reported a position in ZBH in Q4 2020 and has held it in 23 quarters since. The position peaked at $58K in Q1 2021. 130 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Wolff Wiese Magana held 25 shares of Zimmer Biomet worth $2.15K as of Q2 2026.
  • Wolff Wiese Magana left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #814 holding.
  • Wolff Wiese Magana first reported a position in Zimmer Biomet in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Zimmer Biomet position peaked at $58K in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.